Back to search

Ireland· IE-PA-PA2299/025/001

TISSEEL Ready to use Solutions for Sealant

A local hemostatics product containing human fibrinogen + aprotinin + human factor xiii + human thrombin, registered in Ireland by Baxter Holding B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC B02BC

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTISSEEL Ready to use Solutions for Se…ATCB02BCREGISTER NO.IE-PA-PA2299/025/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Human fibrinogen + aprotinin + human factor xiii + human thrombin is registered in 7 of 19 countries.

Countries holding a registration under ATC B02BC (local hemostatics), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Human fibrinogen + aprotinin + human factor xiii + human thrombin · ATC B02BC

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Human fibrinogen + Aprotinin + Human factor xiii + Human thrombin
Manufacturer
Baxter Holding B.V.
Country
Ireland (IE)
ATC code
B02BC
ATC class
Local hemostatics
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2299/025/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human fibrinogen + aprotinin + human factor xiii + human thrombin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human fibrinogen + aprotinin + human factor xiii + human thrombin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5530c22d-4a4b-4bf7-b622-321d0d172dcd
GET /v1/drugs/5530c22d-4a4b-4bf7-b622-321d0d172dcd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for sealant",
  "routes": [
    "Epilesional use"
  ],
  "source": "hpra",
  "atc_all": [
    "B02BC",
    "V03AK"
  ],
  "strength": null,
  "pa_number": "PA2299/025/001",
  "substances": [
    "Human fibrinogen",
    "Aprotinin",
    "Human factor xiii",
    "Human thrombin",
    "Calcium chloride"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "19/11/2010",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about human fibrinogen + aprotinin + human factor xiii + human thrombin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.